DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
143.59
-0.04 (-0.03%)
May 9, 2025, 11:24 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
US Dialysis
11.32B
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Growth
4.33%
Log In
Log In
Log In
Log In
Upgrade
Other - Ancillary Dialysis
1.50B
Log In
Log In
Log In
Log In
Upgrade
Other - Ancillary Dialysis Growth
15.89%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
US Dialysis Segment Operating Income
2.12B
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Segment Operating Income Growth
19.52%
Log In
Log In
Log In
Log In
Upgrade
Other - Ancillary Services Segment Operating Income
82.66M
Log In
Log In
Log In
Log In
Upgrade
Other - Ancillary Services Segment Operating Income Growth
-1044.98%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
US Dialysis Treatment Volume
29.05M
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Treatment Volume Growth
0.33%
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Average Treatments per Day
92.53K
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Average Treatments per Day Growth
-0.81%
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Average Patient Service Revenue per Treatment
391.32
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Average Patient Service Revenue per Treatment Growth
3.68%
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Treatment Days
313.90
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Treatment Days Growth
1.67%
Log In
Log In
Log In
Log In
Upgrade
US Dialysis Normalized Non-Acquired Treatment Growth
-
Log In
Log In
Log In
Log In
Upgrade